TIDMGSK

RNS Number : 3494M

GlaxoSmithKline PLC

20 September 2021

GlaxoSmithKline plc

Director Declaration

GlaxoSmithKline plc announces, pursuant to the Financial Conduct Authority's Listing Rule 9.6.14(2), that Dr Vivienne Cox CBE, Non-Executive Director, has been appointed as a non-executive director and Chair-designate of Victrex plc with effect from 1 December 2021 and 1 January 2022 respectively. Dr Cox will assume responsibility as Chair of Victrex plc with effect from 11 February 2022.

V A Whyte

Company Secretary

20 September 2021

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

RDNEADNEALEFEFA

(END) Dow Jones Newswires

September 20, 2021 09:42 ET (13:42 GMT)

Grafico Azioni Glaxosmithkline (LSE:GSK)
Storico
Da Set 2021 a Ott 2021 Clicca qui per i Grafici di Glaxosmithkline
Grafico Azioni Glaxosmithkline (LSE:GSK)
Storico
Da Ott 2020 a Ott 2021 Clicca qui per i Grafici di Glaxosmithkline